Cargando…
Identification of immune subtypes of cervical squamous cell carcinoma predicting prognosis and immunotherapy responses
BACKGROUND: The main limitation of current immune checkpoint inhibitors (ICIs) in the treatment of cervical cancer comes from the fact that it benefits only a minority of patients. The study aims to develop a classification system to identify immune subtypes of cervical squamous cell carcinoma (SCC)...
Autores principales: | Li, Yimin, Lu, Shun, Wang, Shubin, Peng, Xinhao, Lang, Jinyi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8142504/ https://www.ncbi.nlm.nih.gov/pubmed/34030694 http://dx.doi.org/10.1186/s12967-021-02894-3 |
Ejemplares similares
-
A prognostic nomogram integrating novel biomarkers identified by machine learning for cervical squamous cell carcinoma
por: Li, Yimin, et al.
Publicado: (2020) -
Identification of immune related molecular subtypes and prognosis model for predicting prognosis, drug resistance in cervical squamous cell carcinoma
por: Hu, Dongzhi, et al.
Publicado: (2023) -
Identification of Immune Subtypes for Predicting the Prognosis of Patients in Head and Neck Squamous
Cell Carcinoma
por: Sun, Jing, et al.
Publicado: (2021) -
Identification of Immune Subtypes of Esophageal Adenocarcinoma to Predict Prognosis and Immunotherapy Response
por: Ling, Chen, et al.
Publicado: (2022) -
Identification of cell senescence molecular subtypes in prediction of the prognosis and immunotherapy of hepatitis B virus-related hepatocellular carcinoma
por: Yu, Xue, et al.
Publicado: (2022)